Britain on course to produce another 60million Covid vaccines as UK-based Novavax jab PASSES phase three trial with stunning 90% success rate (including quashing...
US biotech firm Novavax announced its vaccine had successfully completed its Phase Three clinical trials in the UK, paving the way for regulators to give final approval in the comi…
